Investigating late onset decentration in iris-fixated pIOLs

Article

We look into whether pIOLs stay in position after implantation in the long term, preventing damage to intraocular tissues and retain a good quality of vision.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Abdelrahman Elhusseiny, MD, MSc, discusses his AAO presentation on risk of posterior capsular rupture in fellow-eyes cataract surgery
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
Marjorie Rah, OD, PhD, FAAO
Josefina Botta, MD, MSc, at ASCRS 2024
Related Content
Frank Kerkhoff, MD, PhD, and visual acuity charts following implantation with the Johnson and Johnson Tecnis Odyssey lens.

Q&A: Early research findings and clinical experiences with a new multifocal IOL

Frank Kerkhoff, MD, PhD ;Hattie Hayes
July 17th 2025
Article

Frank Kerkhoff, MD, shares his experiences with the Johnson & Johnson Tecnis Odyssey lens

A row of beakers with yellow and orange fluid in a laboratory. Concept image for microbial lutein production, bioengineering, sustainable synthesis for cataract cornea age-related macular degeneration (AMD) and retinal disease. Image credit: bidala – stock.adobe.com

New microbial strain produces high yields of lutein for AMD, cataract prevention

Kassi Filkins
July 15th 2025
Article

Researchers at the Korea Advanced Institute of Science and Technology demonstrated the next-generation strategy for sustainable synthesis

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients

Jordana Joy
July 12th 2025
Article

Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.

A Canadian flag in front of a mountain range. Concept image for Alcon Clareon Panoptix Pro intraocular lens IOL launch and approval in Canada. Image credit: ©toptop54 from pixabay - Canva.com

Clareon Panoptix Pro IOL (Alcon) approved in Canada

Jordana Joy
July 9th 2025
Article

The trifocal IOL is designed to deliver lower light scatter and higher-reported light utilisation

Nationwide free transport for cataract patients through SpaMedica

Nationwide free transport for cataract patients through SpaMedica

Lynda Charters
July 8th 2025
Article

SpaMedica to offer free transport for all NHS cataract patients, supporting community care and reducing health inequalities.

A person's hands are visible as they search in a file cabinet. Concept image for new categorisation of intraocular lens. Image credit: ©Stephen Coburn – stock.adobe.com

How a newly defined category of IOLs can benefit patient outcomes

Joaquín Fernández Pérez, MD, PhD, MSc
June 30th 2025
Article

A new functional classification can help achieve precise vision goals

© 2025 MJH Life Sciences

All rights reserved.